{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:03:54Z","timestamp":1791299034234,"version":"4.1.0"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00705-021-04958-7","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T17:04:48Z","timestamp":1610989488000},"page":"675-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV"],"prefix":"10.1007","volume":"166","author":[{"given":"Nima","family":"Hemmat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Asadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noora Karim","family":"Ahangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Alemohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basira","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Derakhshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Baghbanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Bannazadeh","family":"Baghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Javadrashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriadeg","family":"Ar Gouilh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"issue":"7181","key":"4958_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/nature06536","volume":"451","author":"KE Jones","year":"2008","unstructured":"Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global trends in emerging infectious diseases. Nature 451(7181):990\u2013993","journal-title":"Nature"},{"key":"4958_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fonc.2020.00734","volume":"10","author":"O Brunetti","year":"2020","unstructured":"Brunetti O, Derakhshani A, Baradaran B, Galvano A, Russo A, Silvestris N (2020) COVID-19 infection in cancer patients: how can oncologists deal with these patients? Front Oncol 10:734","journal-title":"Front Oncol"},{"issue":"20","key":"4958_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa030685","volume":"348","author":"N Lee","year":"2003","unstructured":"Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung C, To K (2003) A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 348(20):1986\u20131994","journal-title":"N Engl J Med"},{"issue":"19","key":"4958_CR4","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367(19):1814\u20131820","journal-title":"N Engl J Med"},{"key":"4958_CR5","doi-asserted-by":"crossref","unstructured":"Sampathkumar P, Temesgen Z, Smith TF, Thompson RL (2003) SARS: epidemiology, clinical presentation, management, and infection control measures. In: Mayo Clinic Proceedings, 2003, vol 7. Elsevier, pp 882\u2013890","DOI":"10.4065\/78.7.882"},{"key":"4958_CR6","unstructured":"Organization WH (2004) SARS (Severe Acute Respiratory Syndrome). https:\/\/www.who.int\/ith\/diseases\/sars\/en\/"},{"issue":"26","key":"4958_CR7","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.vaccine.2016.03.104","volume":"34","author":"K Modjarrad","year":"2016","unstructured":"Modjarrad K (2016) MERS-CoV vaccine candidates in development: the current landscape. Vaccine 34(26):2982\u20132987","journal-title":"Vaccine"},{"key":"4958_CR8","unstructured":"Organization WH (2019,) Middle East respiratory syndrome coronavirus (MERS-CoV) https:\/\/www.who.int\/emergencies\/mers-cov\/en\/"},{"issue":"3","key":"4958_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MCP.0000000000000046","volume":"20","author":"DS Hui","year":"2014","unstructured":"Hui DS, Memish ZA, Zumla A (2014) Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulmon Med 20(3):233\u2013241","journal-title":"Curr Opin Pulmon Med"},{"issue":"5","key":"4958_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2796.2010.02222.x","volume":"267","author":"V Kaminskyy","year":"2010","unstructured":"Kaminskyy V, Zhivotovsky B (2010) To kill or be killed: how viruses interact with the cell death machinery. J Intern Med 267(5):473\u2013482","journal-title":"J Intern Med"},{"issue":"3","key":"4958_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00001432-200206000-00008","volume":"15","author":"N Grandvaux","year":"2002","unstructured":"Grandvaux N, Servant MJ, Hiscott J (2002) The interferon antiviral response: from viral invasion to evasion. Curr Opin Infect Dis 15(3):259\u2013267","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"4958_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14(8):523","journal-title":"Nat Rev Microbiol"},{"key":"4958_CR13","doi-asserted-by":"crossref","unstructured":"Kindler E, Thiel V, Weber F (2016) Interaction of SARS and MERS coronaviruses with the antiviral interferon response. In: Advances in virus research, vol 96. Elsevier, pp 219\u2013243","DOI":"10.1016\/bs.aivir.2016.08.006"},{"issue":"2","key":"4958_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/resp.13196","volume":"23","author":"Y Yin","year":"2018","unstructured":"Yin Y, Wunderink RG (2018) MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 23(2):130\u2013137","journal-title":"Respirology"},{"issue":"1","key":"4958_CR15","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38(1):1\u20139","journal-title":"Asian Pac J Allergy Immunol"},{"key":"4958_CR16","first-page":"174","volume":"28","author":"AA Rabaan","year":"2020","unstructured":"Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020) SARS-CoV-2, SARS-CoV, and MERSCOV: a comparative overview. Infez Med 28:174\u2013184","journal-title":"Infez Med"},{"key":"4958_CR17","doi-asserted-by":"crossref","unstructured":"Tyrrell D, Bynoe M (1966) Cultivation of viruses from a high proportion of patients with colds. Lancet 76\u201377","DOI":"10.1016\/S0140-6736(66)92364-6"},{"issue":"1","key":"4958_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3181\/00379727-121-30734","volume":"121","author":"D Hamre","year":"1966","unstructured":"Hamre D, Procknow JJ (1966) A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121(1):190\u2013193","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"4958_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1099\/0022-1317-1-2-175","volume":"1","author":"JD Almeida","year":"1967","unstructured":"Almeida JD, Tyrrell D (1967) The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol 1(2):175\u2013178","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"4958_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000149883","volume":"5","author":"D Tyrrell","year":"1975","unstructured":"Tyrrell D, Almeida J, Cunningham C, Dowdle W, Hofstad M, McIntosh K, Tajima M, Zakstelskaya LY, Easterday B, Kapikian A (1975) Coronaviridae. Intervirology 5(1\u20132):76\u201382","journal-title":"Intervirology"},{"issue":"11","key":"4958_CR21","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","volume":"24","author":"JS Kahn","year":"2005","unstructured":"Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24(11):S223\u2013S227","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"4958_CR22","doi-asserted-by":"publisher","first-page":"7790","DOI":"10.1128\/JVI.01244-13","volume":"87","author":"RJ de Groot","year":"2013","unstructured":"de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA (2013) Commentary: Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87(14):7790\u20137792","journal-title":"J Virol"},{"key":"4958_CR23","first-page":"536","volume":"1","author":"Of the International CSG","year":"2020","unstructured":"Of the International CSG (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 1:536\u2013544","journal-title":"Nat Microbiol"},{"key":"4958_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","volume":"64","author":"CA de Haan","year":"2005","unstructured":"de Haan CA, Rottier PJ (2005) Molecular interactions in the assembly of coronaviruses. Adv Virus Res 64:165\u2013230","journal-title":"Adv Virus Res"},{"issue":"8","key":"4958_CR25","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3390\/v6082991","volume":"6","author":"R McBride","year":"2014","unstructured":"McBride R, Van Zyl M, Fielding BC (2014) The coronavirus nucleocapsid is a multifunctional protein. Viruses 6(8):2991\u20133018","journal-title":"Viruses"},{"issue":"1","key":"4958_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","volume":"16","author":"D Schoeman","year":"2019","unstructured":"Schoeman D, Fielding BC (2019) Coronavirus envelope protein: current knowledge. Virol J 16(1):69","journal-title":"Virol J"},{"key":"4958_CR27","doi-asserted-by":"crossref","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. In: Coronaviruses. Springer, pp 1\u201323","DOI":"10.1007\/978-1-4939-2438-7_1"},{"issue":"9422","key":"4958_CR28","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/S0140-6736(04)16255-7","volume":"363","author":"PK Cheng","year":"2004","unstructured":"Cheng PK, Wong DA, Tong LK, Ip S-M, Lo AC, Lau C-S, Yeung EY, Lim WW (2004) Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet 363(9422):1699\u20131700","journal-title":"Lancet"},{"issue":"6377","key":"4958_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/357420a0","volume":"357","author":"CL Yeager","year":"1992","unstructured":"Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357(6377):420\u2013422","journal-title":"Nature"},{"issue":"6","key":"4958_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/092986707780059571","volume":"14","author":"Y Luan","year":"2007","unstructured":"Luan Y, Xu W (2007) The structure and main functions of aminopeptidase N. Curr Med Chem 14(6):639\u2013647","journal-title":"Curr Med Chem"},{"issue":"1","key":"4958_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner A, Navis G, van Goor H (2007) The emerging role of ACE2 in physiology and disease. J Pathol 212(1):1\u201311","journal-title":"J Pathol"},{"issue":"22","key":"4958_CR32","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1073\/pnas.0409465102","volume":"102","author":"H Hofmann","year":"2005","unstructured":"Hofmann H, Pyrc K, van der Hoek L, Geier M, Berkhout B, P\u00f6hlmann S (2005) Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci 102(22):7988\u20137993","journal-title":"Proc Natl Acad Sci"},{"issue":"6965","key":"4958_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450\u2013454","journal-title":"Nature"},{"issue":"4","key":"4958_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5(4):562\u2013569","journal-title":"Nat Microbiol"},{"issue":"7","key":"4958_CR35","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1128\/jvi.68.7.4525-4537.1994","volume":"68","author":"P Nedellec","year":"1994","unstructured":"Nedellec P, Dveksler GS, Daniels E, Turbide C, Chow B, Basile AA, Holmes KV, Beauchemin N (1994) Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J Virol 68(7):4525\u20134537","journal-title":"J Virol"},{"issue":"7440","key":"4958_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj VS, Mou H, Smits SL, Dekkers DH, M\u00fcller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495(7440):251\u2013254","journal-title":"Nature"},{"issue":"14","key":"4958_CR37","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci 106(14):5871\u20135876","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4958_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","volume":"81","author":"J Ziebuhr","year":"2000","unstructured":"Ziebuhr J, Snijder EJ, Gorbalenya AE (2000) Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81(4):853\u2013879","journal-title":"J Gen Virol"},{"key":"4958_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.virusres.2014.01.025","volume":"194","author":"AM Mielech","year":"2014","unstructured":"Mielech AM, Chen Y, Mesecar AD, Baker SC (2014) Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities. Virus Res 194:184\u2013190","journal-title":"Virus Res"},{"issue":"6489","key":"4958_CR40","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368(6489):409\u2013412","journal-title":"Science"},{"issue":"1","key":"4958_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1083\/jcb.124.1.55","volume":"124","author":"J Krijnse-Locker","year":"1994","unstructured":"Krijnse-Locker J, Ericsson M, Rottier P, Griffiths G (1994) Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol 124(1):55\u201370","journal-title":"J Cell Biol"},{"key":"4958_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.tim.2020.05.009","volume":"28","author":"G Wolff","year":"2020","unstructured":"Wolff G, Melia CE, Snijder EJ, B\u00e1rcena M (2020) Double-membrane vesicles as platforms for viral replication. Trends Microbiol 28:1022\u20131033","journal-title":"Trends Microbiol"},{"issue":"8","key":"4958_CR43","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.4014\/jmb.1908.08004","volume":"29","author":"JY Lee","year":"2019","unstructured":"Lee JY, Bae S, Myoung J (2019) Middle East Respiratory Syndrome coronavirus-encoded accessory proteins impair MDA5-and TBK1-mediated activation of NF-kappaB. J Microbiol Biotechnol 29(8):1316\u20131323","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"4958_CR44","doi-asserted-by":"publisher","first-page":"e1006838","DOI":"10.1371\/journal.ppat.1006838","volume":"14","author":"J Canton","year":"2018","unstructured":"Canton J, Fehr AR, Fernandez-Delgado R, Gutierrez-Alvarez FJ, Sanchez-Aparicio MT, Garcia-Sastre A, Perlman S, Enjuanes L, Sola I (2018) MERS-CoV 4b protein interferes with the NF-kappaB-dependent innate immune response during infection. PLoS Pathog 14(1):e1006838","journal-title":"PLoS Pathog"},{"issue":"2","key":"4958_CR45","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1128\/JVI.02576-13","volume":"88","author":"ML DeDiego","year":"2014","unstructured":"DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guardeno JM, Fernandez-Delgado R, Fett C, Castano-Rodriguez C, Perlman S, Enjuanes L (2014) Inhibition of NF-kappaB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 88(2):913\u2013924","journal-title":"J Virol"},{"issue":"8","key":"4958_CR46","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.1096\/fj.201802418R","volume":"33","author":"KL Siu","year":"2019","unstructured":"Siu KL, Yuen KS, Castano-Rodriguez C, Ye ZW, Yeung ML, Fung SY, Yuan S, Chan CP, Yuen KY, Enjuanes L (2019) Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J 33(8):8865\u20138877","journal-title":"FASEB J"},{"key":"4958_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.virol.2015.08.010","volume":"485","author":"JL Nieto-Torres","year":"2015","unstructured":"Nieto-Torres JL, Verdia-Baguena C, Jimenez-Guardeno JM, Regla-Nava JA, Castano-Rodriguez C, Fernandez-Delgado R, Torres J, Aguilella VM, Enjuanes L (2015) Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology 485:330\u2013339","journal-title":"Virology"},{"issue":"1","key":"4958_CR48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/22221751.2020.1736644","volume":"9","author":"SY Fung","year":"2020","unstructured":"Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY (2020) A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect 9(1):558\u2013570","journal-title":"Emerg Microbes Infect"},{"issue":"30","key":"4958_CR49","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.1016\/j.febslet.2006.11.046","volume":"580","author":"N Kanzawa","year":"2006","unstructured":"Kanzawa N, Nishigaki K, Hayashi T, Ishii Y, Furukawa S, Niiro A, Yasui F, Kohara M, Morita K, Matsushima K (2006) Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a\/X1 and 7a\/X4 proteins through NF-\u03baB activation. FEBS Lett 580(30):6807\u20136812","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"4958_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","volume":"128","author":"W Wang","year":"2007","unstructured":"Wang W, Ye L, Ye L, Li B, Gao B, Zeng Y, Kong L, Fang X, Zheng H, Wu Z (2007) Up-regulation of IL-6 and TNF-\u03b1 induced by SARS-coronavirus spike protein in murine macrophages via NF-\u03baB pathway. Virus Res 128(1\u20132):1\u20138","journal-title":"Virus Res"},{"key":"4958_CR51","doi-asserted-by":"crossref","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O\u2019Meara MJ, Guo JZ, Swaney DL, Tummino TA, Huettenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, Haas K, Modak M, Kim M, Haas P, Polacco BJ, Braberg H, Fabius JM, Eckhardt M, Soucheray M, Bennett MJ, Cakir M, McGregor MJ, Li Q, Naing ZZC, Zhou Y, Peng S, Kirby IT, Melnyk JE, Chorba JS, Lou K, Dai SA, Shen W, Shi Y, Zhang Z, Barrio-Hernandez I, Memon D, Hernandez-Armenta C, Mathy CJP, Perica T, Pilla KB, Ganesan SJ, Saltzberg DJ, Ramachandran R, Liu X, Rosenthal SB, Calviello L, Venkataramanan S, Liboy-Lugo J, Lin Y, Wankowicz SA, Bohn M, Sharp PP, Trenker R, Young JM, Cavero DA, Hiatt J, Roth TL, Rathore U, Subramanian A, Noack J, Hubert M, Roesch F, Vallet T, Meyer B, White KM, Miorin L, Rosenberg OS, Verba KA, Agard D, Ott M, Emerman M, Ruggero D, Garc\u00eda-Sastre A, Jura N, von Zastrow M, Taunton J, Ashworth A, Schwartz O, Vignuzzi M, d\u2019Enfert C, Mukherjee S, Jacobson M, Malik HS, Fujimori DG, Ideker T, Craik CS, Floor S, Fraser JS, Gross J, Sali A, Kortemme T, Beltrao P, Shokat K, Shoichet BK, Krogan NJ (2020) A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv 2020.2003.2022.002386","DOI":"10.1101\/2020.03.22.002386"},{"issue":"2","key":"4958_CR52","doi-asserted-by":"publisher","first-page":"e1967","DOI":"10.1002\/rmv.1967","volume":"28","author":"H Mirzaei","year":"2018","unstructured":"Mirzaei H, Faghihloo E (2018) Viruses as key modulators of the TGF-beta pathway; a double-edged sword involved in cancer. Rev Med Virol 28(2):e1967","journal-title":"Rev Med Virol"},{"issue":"3","key":"4958_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.2067","volume":"210","author":"L He","year":"2006","unstructured":"He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J (2006) Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol 210(3):288\u2013297","journal-title":"J Pathol"},{"key":"4958_CR54","doi-asserted-by":"publisher","first-page":"25754","DOI":"10.1038\/srep25754","volume":"6","author":"SW Li","year":"2016","unstructured":"Li SW, Wang CY, Jou YJ, Yang TC, Huang SH, Wan L, Lin YJ, Lin CW (2016) SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-beta1 via ROS\/p38 MAPK\/STAT3 pathway. Sci Rep 6:25754","journal-title":"Sci Rep"},{"key":"4958_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.virusres.2017.04.008","volume":"235","author":"CY Wang","year":"2017","unstructured":"Wang CY, Lu CY, Li SW, Lai CC, Hua CH, Huang SH, Lin YJ, Hour MJ, Lin CW (2017) SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-beta1 signaling. Virus Res 235:58\u201366","journal-title":"Virus Res"},{"issue":"6","key":"4958_CR56","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1074\/jbc.M708033200","volume":"283","author":"X Zhao","year":"2008","unstructured":"Zhao X, Nicholls JM, Chen YG (2008) Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem 283(6):3272\u20133280","journal-title":"J Biol Chem"},{"key":"4958_CR57","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1038\/nmicrobiol.2016.4","volume":"1","author":"ML Yeung","year":"2016","unstructured":"Yeung ML, Yao Y, Jia L, Chan JF, Chan KH, Cheung KF, Chen H, Poon VK, Tsang AK, To KK, Yiu MK, Teng JL, Chu H, Zhou J, Zhang Q, Deng W, Lau SK, Lau JY, Woo PC, Chan TM, Yung S, Zheng BJ, Jin DY, Mathieson PW, Qin C, Yuen KY (2016) MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol 1:16004","journal-title":"Nat Microbiol"},{"issue":"12","key":"4958_CR58","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","volume":"79","author":"CY Cheung","year":"2005","unstructured":"Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 79(12):7819\u20137826","journal-title":"J Virol"},{"issue":"7","key":"4958_CR59","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","volume":"106","author":"HK Law","year":"2005","unstructured":"Law HK, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JM, Lau YL (2005) Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells. Blood 106(7):2366\u20132374","journal-title":"Blood"},{"key":"4958_CR60","doi-asserted-by":"crossref","unstructured":"Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS (2020) Targeted immunosuppression distinguishes COVID-19 from influenza in moderate and severe disease. medRxiv","DOI":"10.1101\/2020.05.28.20115667"},{"issue":"5","key":"4958_CR61","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1210\/endo.138.5.5239","volume":"138","author":"M Weber","year":"1997","unstructured":"Weber M, Michl P, Auernhammer C, Engelhardt D (1997) Interleukin-3 and interleukin-6 stimulate cortisol secretion from adult human adrenocortical cells. Endocrinology 138(5):2207\u20132210","journal-title":"Endocrinology"},{"issue":"5","key":"4958_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/ijms17050678","volume":"17","author":"S-W Li","year":"2016","unstructured":"Li S-W, Wang C-Y, Jou Y-J, Huang S-H, Hsiao L-H, Wan L, Lin Y-J, Kung S-H, Lin C-W (2016) SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked polyubiquitination of TRAF3 and TRAF6. Int J Mol Sci 17(5):678","journal-title":"Int J Mol Sci"},{"key":"4958_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","volume":"5","author":"CS Shi","year":"2019","unstructured":"Shi CS, Nabar NR, Huang NN, Kehrl JH (2019) SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov 5:101","journal-title":"Cell Death Discov"},{"issue":"6","key":"4958_CR64","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.4049\/jimmunol.173.6.4030","volume":"173","author":"WG Glass","year":"2004","unstructured":"Glass WG, Subbarao K, Murphy B, Murphy PM (2004) Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 173(6):4030\u20134039","journal-title":"J Immunol"},{"key":"4958_CR65","doi-asserted-by":"crossref","unstructured":"Alosaimi B, Hamed M, Naeem A, Alsharef A, Alqahtani S, Aldosari K, Alamri A, Al-Eisa K, Khojah T, Assiri A, Enani M (2019) MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines\/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine 126","DOI":"10.1016\/j.cyto.2019.154895"},{"issue":"11","key":"4958_CR66","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3346\/jkms.2016.31.11.1717","volume":"31","author":"ES Kim","year":"2016","unstructured":"Kim ES, Choe PG, Park WB, Oh HS, Kim EJ, Nam EY, Na SH, Kim M, Song K-H, Bang JH (2016) Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection. J Korean Med Sci 31(11):1717\u20131725","journal-title":"J Korean Med Sci"},{"key":"4958_CR67","unstructured":"Deng X, Yu X, Pei J (2020) Regulation of interferon production as a potential strategy for COVID-19 treatment"},{"issue":"4","key":"4958_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420\u2013422","journal-title":"Lancet Respir Med"},{"key":"4958_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cytogfr.2020.06.014","volume":"54","author":"BS Johnson","year":"2020","unstructured":"Johnson BS, Laloraya M (2020) Cytokine storm in COVID-19 patients transforms to a cytokine super cyclone in patients with risk factors. Cytokine Growth Fact Rev 54:32\u201342","journal-title":"Cytokine Growth Fact Rev"},{"key":"4958_CR70","doi-asserted-by":"crossref","unstructured":"Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S, Chufang L, Jin Z, Zhenhua J, Haiming J (2020) Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res 104761","DOI":"10.1016\/j.phrs.2020.104761"},{"key":"4958_CR71","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827","journal-title":"Front Immunol"},{"issue":"2","key":"4958_CR72","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, Perlman S (2016) Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19(2):181\u2013193","journal-title":"Cell Host Microbe"},{"issue":"12","key":"4958_CR73","doi-asserted-by":"publisher","first-page":"a000893","DOI":"10.1101\/cshperspect.a000893","volume":"2","author":"D Lane","year":"2010","unstructured":"Lane D, Levine A (2010) p53 research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol 2(12):a000893","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4958_CR74","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","volume":"85","author":"AC Joerger","year":"2016","unstructured":"Joerger AC, Fersht AR (2016) The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem 85:375\u2013404","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"4958_CR75","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137(3):413\u2013431","journal-title":"Cell"},{"issue":"2","key":"4958_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li Y-C, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13(2):83\u201396","journal-title":"Nat Rev Cancer"},{"issue":"6630","key":"4958_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/387296a0","volume":"387","author":"Y Haupt","year":"1997","unstructured":"Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387(6630):296\u2013299","journal-title":"Nature"},{"issue":"1","key":"4958_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/v2010298","volume":"2","author":"C Rivas","year":"2010","unstructured":"Rivas C, Aaronson SA, Munoz-Fontela C (2010) Dual role of p53 in innate antiviral immunity. Viruses 2(1):298\u2013313","journal-title":"Viruses"},{"issue":"4","key":"4958_CR79","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/rmv.1738","volume":"23","author":"Y Sato","year":"2013","unstructured":"Sato Y, Tsurumi T (2013) Genome guardian p53 and viral infections. Rev Med Virol 23(4):213\u2013220","journal-title":"Rev Med Virol"},{"issue":"6948","key":"4958_CR80","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01850","volume":"424","author":"A Takaoka","year":"2003","unstructured":"Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K (2003) Integration of interferon-\u03b1\/\u03b2 signalling to p53 responses in tumour suppression and antiviral defence. Nature 424(6948):516\u2013523","journal-title":"Nature"},{"issue":"8","key":"4958_CR81","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.20080383","volume":"205","author":"C Mu\u00f1oz-Fontela","year":"2008","unstructured":"Mu\u00f1oz-Fontela C, Macip S, Mart\u00ednez-Sobrido L, Brown L, Ashour J, Garc\u00eda-Sastre A, Lee SW, Aaronson SA (2008) Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 205(8):1929\u20131938","journal-title":"J Exp Med"},{"issue":"16","key":"4958_CR82","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.1128\/JVI.75.16.7572-7582.2001","volume":"75","author":"H Nakamura","year":"2001","unstructured":"Nakamura H, Li M, Zarycki J, Jung JU (2001) Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75(16):7572\u20137582","journal-title":"J Virol"},{"issue":"3","key":"4958_CR83","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1128\/jvi.71.3.1739-1746.1997","volume":"71","author":"JG Teodoro","year":"1997","unstructured":"Teodoro JG, Branton PE (1997) Regulation of apoptosis by viral gene products. J Virol 71(3):1739","journal-title":"J Virol"},{"issue":"5","key":"4958_CR84","doi-asserted-by":"publisher","first-page":"e38052","DOI":"10.1371\/journal.pone.0038052","volume":"7","author":"T Bian","year":"2012","unstructured":"Bian T, Gibbs JD, \u00d6rvell C, Imani F (2012) Respiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathway. PLoS ONE 7(5):e38052","journal-title":"PLoS ONE"},{"issue":"14","key":"4958_CR85","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1128\/JVI.79.14.8802-8811.2005","volume":"79","author":"E Turpin","year":"2005","unstructured":"Turpin E, Luke K, Jones J, Tumpey T, Konan K, Schultz-Cherry S (2005) Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol 79(14):8802\u20138811","journal-title":"J Virol"},{"issue":"19","key":"4958_CR86","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1128\/JVI.78.19.10410-10419.2004","volume":"78","author":"C-J Chen","year":"2004","unstructured":"Chen C-J, Sugiyama K, Kubo H, Huang C, Makino S (2004) Murine coronavirus nonstructural protein p28 arrests cell cycle in G0\/G1 phase. J Virol 78(19):10410\u201310419","journal-title":"J Virol"},{"issue":"1","key":"4958_CR87","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1165\/rcmb.2005-0345RC","volume":"37","author":"X Yuan","year":"2007","unstructured":"Yuan X, Yao Z, Wu J, Zhou Y, Shan Y, Dong B, Zhao Z, Hua P, Chen J, Cong Y (2007) G1 phase cell cycle arrest induced by SARS-CoV 3a protein via the cyclin D3\/pRb pathway. Am J Respir Cell Mol Biol 37(1):9\u201319","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"4958_CR88","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1074\/jbc.M114.619890","volume":"290","author":"L Yuan","year":"2015","unstructured":"Yuan L, Chen Z, Song S, Wang S, Tian C, Xing G, Chen X, Xiao Z-X, He F, Zhang L (2015) p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling. J Biol Chem 290(5):3172\u20133182","journal-title":"J Biol Chem"},{"issue":"35","key":"4958_CR89","doi-asserted-by":"publisher","first-page":"E5192","DOI":"10.1073\/pnas.1603435113","volume":"113","author":"Y Ma-Lauer","year":"2016","unstructured":"Ma-Lauer Y, Carbajo-Lozoya J, Hein MY, M\u00fcller MA, Deng W, Lei J, Meyer B, Kusov Y, von Brunn B, Bairad DR (2016) p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1. Proc Natl Acad Sci 113(35):E5192\u2013E5201","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"4958_CR90","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1099\/vir.0.83665-0","volume":"89","author":"K Padhan","year":"2008","unstructured":"Padhan K, Minakshi R, Towheed MAB, Jameel S (2008) Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol 89(8):1960\u20131969","journal-title":"J Gen Virol"},{"issue":"1","key":"4958_CR91","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","volume":"9","author":"Y Xiong","year":"2020","unstructured":"Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, Guo D, Hu W, Yang J, Tang Z (2020) Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect 9(1):761\u2013770","journal-title":"Emerg Microbes Infect"},{"key":"4958_CR92","doi-asserted-by":"publisher","first-page":"104791","DOI":"10.1016\/j.antiviral.2020.104791","volume":"178","author":"E Sallard","year":"2020","unstructured":"Sallard E, Lescure F-X, Yazdanpanah Y, Mentre F, Peiffer-Smadja N, Florence A, Yazdanpanah Y, Mentre F, Lescure F-X, Peiffer-Smadja N (2020) Type 1 interferons as a potential treatment against COVID-19. Antivir Res 178:104791","journal-title":"Antivir Res"},{"issue":"6","key":"4958_CR93","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000279388","volume":"77","author":"G Lurje","year":"2009","unstructured":"Lurje G, Lenz H-J (2009) EGFR signaling and drug discovery. Oncology 77(6):400\u2013410","journal-title":"Oncology"},{"key":"4958_CR94","doi-asserted-by":"crossref","unstructured":"Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A (2006) The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochimica et Biophysica Acta (BBA) Rev Cancer 1766(1):120\u2013139","DOI":"10.1016\/j.bbcan.2006.06.001"},{"issue":"16","key":"4958_CR95","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1089\/104303401753204544","volume":"12","author":"AA Samani","year":"2001","unstructured":"Samani AA, Fallavollita L, Jaalouk DE, Galipeau J, Brodt P (2001) Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense. Hum Gene Ther 12(16):1969\u20131977","journal-title":"Hum Gene Ther"},{"issue":"9","key":"4958_CR96","doi-asserted-by":"publisher","first-page":"e1001099","DOI":"10.1371\/journal.ppat.1001099","volume":"6","author":"T Eierhoff","year":"2010","unstructured":"Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C (2010) The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6(9):e1001099","journal-title":"PLoS Pathog"},{"key":"4958_CR97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2018.05.009","volume":"521","author":"W Hu","year":"2018","unstructured":"Hu W, Zhang S, Shen Y, Yang Q (2018) Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry. Virology 521:33\u201343","journal-title":"Virology"},{"key":"4958_CR98","doi-asserted-by":"crossref","unstructured":"Yang L, Xu J, Guo L, Guo T, Zhang L, Feng L, Chen H, Wang Y (2018) Porcine epidemic diarrhea virus-induced epidermal growth factor receptor activation impairs the antiviral activity of type I interferon. J Virol 92(8)","DOI":"10.1128\/JVI.02095-17"},{"issue":"3","key":"4958_CR99","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/mi.2017.120","volume":"11","author":"A Kalinowski","year":"2018","unstructured":"Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, Clark B, Joerns J, Liu W, Nadel JA (2018) Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol 11(3):958\u2013967","journal-title":"Mucosal Immunol"},{"issue":"4","key":"4958_CR100","doi-asserted-by":"publisher","first-page":"e01340","DOI":"10.1128\/mBio.01340-14","volume":"5","author":"MC Freeman","year":"2014","unstructured":"Freeman MC, Peek CT, Becker MM, Smith EC, Denison MR (2014) Coronaviruses induce entry-independent, continuous macropinocytosis. MBio 5(4):e01340-e11314","journal-title":"MBio"},{"key":"4958_CR101","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1183\/09031936.00146413","volume":"44","author":"S Vallath","year":"2014","unstructured":"Vallath S, Hynds RE, Succony L, Janes SM, Giangreco A (2014) Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities. Eur Respir Soc 44:513\u2013522","journal-title":"Eur Respir Soc"},{"key":"4958_CR102","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.antiviral.2017.03.022","volume":"143","author":"T Venkataraman","year":"2017","unstructured":"Venkataraman T, Frieman MB (2017) The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antivir Res 143:142\u2013150","journal-title":"Antivir Res"},{"issue":"12","key":"4958_CR103","doi-asserted-by":"publisher","first-page":"e00182","DOI":"10.1128\/JVI.00182-17","volume":"91","author":"T Venkataraman","year":"2017","unstructured":"Venkataraman T, Coleman CM, Frieman MB (2017) Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection. J Virol 91(12):e00182-e1117","journal-title":"J Virol"},{"issue":"1","key":"4958_CR104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bph.12432","volume":"171","author":"C Bubici","year":"2014","unstructured":"Bubici C, Papa S (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol 171(1):24\u201337","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4958_CR105","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston CR, Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19(2):142\u2013149","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"4958_CR106","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1074-7613(00)80146-6","volume":"11","author":"W-M Chu","year":"1999","unstructured":"Chu W-M, Ostertag D, Li Z-W, Chang L, Chen Y, Hu Y, Williams B, Perrault J, Karin M (1999) JNK2 and IKK\u03b2 are required for activating the innate response to viral infection. Immunity 11(6):721\u2013731","journal-title":"Immunity"},{"issue":"14","key":"4958_CR107","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1074\/jbc.M009902200","volume":"276","author":"S Ludwig","year":"2001","unstructured":"Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S (2001) Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 276(14):10990\u201310998","journal-title":"J Biol Chem"},{"issue":"5","key":"4958_CR108","first-page":"853","volume":"20","author":"X Li","year":"2016","unstructured":"Li X, Sun S, Wu F, Shi T, Fan H, Li D (2016) Study on JNK\/AP-1 signaling pathway of airway mucus hypersecretion of severe pneumonia under RSV infection. Eur Rev Med Pharmacol Sci 20(5):853\u2013857","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"4958_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-017-0053-0","volume":"8","author":"TS Fung","year":"2017","unstructured":"Fung TS, Liu DX (2017) Activation of the c-Jun NH 2-terminal kinase pathway by coronavirus infectious bronchitis virus promotes apoptosis independently of c-Jun. Cell Death Dis 8(12):1\u201313","journal-title":"Cell Death Dis"},{"issue":"1","key":"4958_CR110","doi-asserted-by":"publisher","first-page":"e30191","DOI":"10.1371\/journal.pone.0030191","volume":"7","author":"Y Zhong","year":"2012","unstructured":"Zhong Y, Liao Y, Fang S, Tam JP, Liu DX (2012) Up-regulation of Mcl-1 and Bak by coronavirus infection of human, avian and animal cells modulates apoptosis and viral replication. PLoS One 7(1):e30191","journal-title":"PLoS One"},{"issue":"2","key":"4958_CR111","first-page":"369","volume":"151","author":"L Bordi","year":"2006","unstructured":"Bordi L, Castilletti C, Falasca L, Ciccosanti F, Calcaterra S, Rozera G, Di Caro A, Zaniratti S, Rinaldi A, Ippolito G (2006) Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics. Adv Virol 151(2):369\u2013377","journal-title":"Adv Virol"},{"issue":"3","key":"4958_CR112","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/diseases4030026","volume":"4","author":"YX Lim","year":"2016","unstructured":"Lim YX, Ng YL, Tam JP, Liu DX (2016) Human coronaviruses: a review of virus\u2013host interactions. Diseases 4(3):26","journal-title":"Diseases"},{"issue":"1","key":"4958_CR113","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbrc.2006.06.086","volume":"347","author":"T Mizutani","year":"2006","unstructured":"Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, Kanaji Y, Shirota K, Kurane I, Morikawa S (2006) Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem Biophys Res Commun 347(1):261\u2013265","journal-title":"Biochem Biophys Res Commun"},{"key":"4958_CR114","doi-asserted-by":"crossref","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2005) JNK and PI3k\/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. Biochimica et Biophysica Acta (BBA) Mol Basis Dis 1741(1\u20132):4\u201310","DOI":"10.1016\/j.bbadis.2005.04.004"},{"issue":"1","key":"4958_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/BJ20040984","volume":"383","author":"M Surjit","year":"2004","unstructured":"Surjit M, Liu B, Jameel S, Chow VT, Lal SK (2004) The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors. Biochem J 383(1):13\u201318","journal-title":"Biochem J"},{"key":"4958_CR116","doi-asserted-by":"crossref","unstructured":"Ye Z, Wong CK, Li P, Xie Y (2008) A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress and JNK-dependent apoptosis. Biochimica et Biophysica Acta (BBA) Gen Subj 1780(12):1383\u20131387","DOI":"10.1016\/j.bbagen.2008.07.009"},{"issue":"24","key":"4958_CR117","doi-asserted-by":"publisher","first-page":"5419","DOI":"10.1021\/bi200303r","volume":"50","author":"B Varshney","year":"2011","unstructured":"Varshney B, Lal SK (2011) SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways. Biochemistry 50(24):5419\u20135425","journal-title":"Biochemistry"},{"issue":"3","key":"4958_CR118","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429(3):403\u2013417","journal-title":"Biochem J"},{"issue":"6824","key":"4958_CR119","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410(6824):37\u201340","journal-title":"Nature"},{"issue":"1","key":"4958_CR120","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jcb.1211","volume":"83","author":"N Juretic","year":"2001","unstructured":"Juretic N, Santib\u00e1\u00f1ez JF, Hurtado C, Mart\u00ednez J (2001) ERK 1, 2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83(1):92\u201398","journal-title":"J Cell Biochem"},{"issue":"23","key":"4958_CR121","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1046\/j.0014-2956.2001.02553.x","volume":"268","author":"G Yosimichi","year":"2001","unstructured":"Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M (2001) CTGF\/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44\/42 MAPK\/extracellular-signal regulated kinase (ERK). Eur J Biochem 268(23):6058\u20136065","journal-title":"Eur J Biochem"},{"issue":"2","key":"4958_CR122","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2007.10.011","volume":"77","author":"M Kono","year":"2008","unstructured":"Kono M, Tatsumi K, Imai AM, Saito K, Kuriyama T, Shirasawa H (2008) Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. Antivir Res 77(2):150\u2013152","journal-title":"Antivir Res"},{"issue":"12","key":"4958_CR123","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1128\/JVI.76.12.5937-5948.2002","volume":"76","author":"S Banerjee","year":"2002","unstructured":"Banerjee S, Narayanan K, Mizutani T, Makino S (2002) Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol 76(12):5937\u20135948","journal-title":"J Virol"},{"issue":"16","key":"4958_CR124","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1128\/JVI.79.16.10147-10154.2005","volume":"79","author":"DC Lee","year":"2005","unstructured":"Lee DC, Cheung C-Y, Law AH, Mok CK, Peiris M, Lau AS (2005) p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol 79(16):10147\u201310154","journal-title":"J Virol"},{"issue":"2","key":"4958_CR125","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.virol.2011.09.003","volume":"420","author":"Y Liao","year":"2011","unstructured":"Liao Y, Wang X, Huang M, Tam JP, Liu DX (2011) Regulation of the p38 mitogen-activated protein kinase and dual-specificity phosphatase 1 feedback loop modulates the induction of interleukin 6 and 8 in cells infected with coronavirus infectious bronchitis virus. Virology 420(2):106\u2013116","journal-title":"Virology"},{"issue":"1","key":"4958_CR126","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1196\/annals.1408.006","volume":"1102","author":"T Mizutani","year":"2007","unstructured":"Mizutani T (2007) Signal Transduction in SARS-CoV-Infected Cells. Ann N Y Acad Sci 1102(1):86\u201395","journal-title":"Ann N Y Acad Sci"},{"issue":"1\u20132","key":"4958_CR127","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.febslet.2004.10.005","volume":"577","author":"T Mizutani","year":"2004","unstructured":"Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S (2004) Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. FEBS Lett 577(1\u20132):187\u2013192","journal-title":"FEBS Lett"},{"issue":"4","key":"4958_CR128","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.bbrc.2004.05.107","volume":"319","author":"T Mizutani","year":"2004","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2004) Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. Biochem Biophys Res Commun 319(4):1228\u20131234","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4958_CR129","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jmv.20094","volume":"73","author":"H Yan","year":"2004","unstructured":"Yan H, Xiao G, Zhang J, Hu Y, Yuan F, Cole DK, Zheng C, Gao GF (2004) SARS coronavirus induces apoptosis in Vero E6 cells. J Med Virol 73(3):323\u2013331","journal-title":"J Med Virol"},{"issue":"2","key":"4958_CR130","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/JVI.80.2.785-793.2006","volume":"80","author":"SA Kopecky-Bromberg","year":"2006","unstructured":"Kopecky-Bromberg SA, Martinez-Sobrido L, Palese P (2006) 7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase. J Virol 80(2):785\u2013793","journal-title":"J Virol"},{"issue":"8","key":"4958_CR131","doi-asserted-by":"publisher","first-page":"e1004320","DOI":"10.1371\/journal.ppat.1004320","volume":"10","author":"JM Jimenez-Guardeno","year":"2014","unstructured":"Jimenez-Guardeno JM, Nieto-Torres JL, DeDiego ML, Regla-Nava JA, Fernandez-Delgado R, Casta\u00f1o-Rodriguez C, Enjuanes L (2014) The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog 10(8):e1004320","journal-title":"PLoS Pathog"},{"issue":"12","key":"4958_CR132","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.4049\/jimmunol.172.12.7841","volume":"172","author":"C-H Lee","year":"2004","unstructured":"Lee C-H, Chen R-F, Liu J-W, Yeh W-T, Chang J-C, Liu P-M, Eng H-L, Lin M-C, Yang KD (2004) Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome. J Immunol 172(12):7841\u20137847","journal-title":"J Immunol"},{"issue":"3","key":"4958_CR133","doi-asserted-by":"publisher","first-page":"e00165","DOI":"10.1128\/mBio.00165-13","volume":"4","author":"L Josset","year":"2013","unstructured":"Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG (2013) Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio 4(3):e00165-e1113","journal-title":"MBio"},{"key":"4958_CR134","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","volume":"144","author":"JM Grimes","year":"2020","unstructured":"Grimes JM, Grimes KV (2020) p38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol 144:63\u201365","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"4958_CR135","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1128\/JVI.73.4.3460-3466.1999","volume":"73","author":"X Yang","year":"1999","unstructured":"Yang X, Gabuzda D (1999) Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 73(4):3460\u20133466","journal-title":"J Virol"},{"issue":"6","key":"4958_CR136","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0968-0004(00)80005-5","volume":"17","author":"SL Pelech","year":"1992","unstructured":"Pelech SL, Sanghera JS (1992) Mitogen-activated protein kinases: versatile transducers for cell signaling. Trends Biochem Sci 17(6):233\u2013238","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"4958_CR137","first-page":"845","volume":"6","author":"S Meloche","year":"1992","unstructured":"Meloche S, Seuwen K, Pages G, Pouyssegur J (1992) Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol 6(5):845\u2013854","journal-title":"Mol Endocrinol"},{"issue":"6259","key":"4958_CR138","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/343651a0","volume":"343","author":"NG Anderson","year":"1990","unstructured":"Anderson NG, Maller JL, Tonks NK, Sturgill TW (1990) Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343(6259):651\u2013653","journal-title":"Nature"},{"issue":"4","key":"4958_CR139","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/j.1460-2075.1991.tb08021.x","volume":"10","author":"D Payne","year":"1991","unstructured":"Payne D, Rossomando A, Martino P, Erickson A, Her J, Shabanowitz J, Hunt D, Weber M, Sturgill T (1991) Identification of the regulatory phosphorylation sites in pp42\/mitogen-activated protein kinase (MAP kinase). EMBO J 10(4):885\u2013892","journal-title":"EMBO J"},{"issue":"14","key":"4958_CR140","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1074\/jbc.273.14.8502","volume":"273","author":"DH Nguyen","year":"1998","unstructured":"Nguyen DH, Hussaini IM, Gonias SL (1998) Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem 273(14):8502\u20138507","journal-title":"J Biol Chem"},{"issue":"2","key":"4958_CR141","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1128\/JVI.01705-06","volume":"81","author":"Y Cai","year":"2007","unstructured":"Cai Y, Liu Y, Zhang X (2007) Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J Virol 81(2):446\u2013456","journal-title":"J Virol"},{"issue":"22","key":"4958_CR142","doi-asserted-by":"publisher","first-page":"23098","DOI":"10.1074\/jbc.M311430200","volume":"279","author":"X Shi-wen","year":"2004","unstructured":"Shi-wen X, Howat SL, Renzoni EA, Holmes A, Pearson JD, Dashwood MR, Bou-Gharios G, Denton CP, du Bois RM, Black CM (2004) Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK\/ERK. J Biol Chem 279(22):23098\u201323103","journal-title":"J Biol Chem"},{"issue":"1","key":"4958_CR143","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00408-005-2560-5","volume":"184","author":"Y Hu","year":"2006","unstructured":"Hu Y, Peng J, Feng D, Chu L, Li X, Jin Z, Lin Z, Zeng Q (2006) Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-\u03b21-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 184(1):33\u201342","journal-title":"Lung"},{"issue":"6","key":"4958_CR144","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2005.09.025","volume":"116","author":"C Vancheri","year":"2005","unstructured":"Vancheri C, Gili E, Failla M, Mastruzzo C, Salinaro ET, LoFurno D, Pistorio MP, La Rosa C, Caruso M, Crimi N (2005) Bradykinin differentiates human lung fibroblasts to a myofibroblast phenotype via the B2 receptor. J Allergy Clin Immunol 116(6):1242\u20131248","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"4958_CR145","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.phrs.2008.02.001","volume":"57","author":"F Caraci","year":"2008","unstructured":"Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, Crimi N, Sortino MA, Nicoletti F, Copani A, Vancheri C (2008) TGF-\u03b21 targets the GSK-3\u03b2\/\u03b2-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 57(4):274\u2013282","journal-title":"Pharmacol Res"},{"issue":"1","key":"4958_CR146","doi-asserted-by":"publisher","first-page":"e30328","DOI":"10.1371\/journal.pone.0030328","volume":"7","author":"W Gao","year":"2012","unstructured":"Gao W, Sun W, Qu B, Cardona CJ, Powell K, Wegner M, Shi Y, Xing Z (2012) Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus. PLoS ONE 7(1):e30328","journal-title":"PLoS ONE"},{"issue":"1","key":"4958_CR147","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/019021400269934","volume":"26","author":"W Chen","year":"2000","unstructured":"Chen W, Monick MM, Carter AB, Hunninghake GW (2000) Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8. Exp Lung Res 26(1):13\u201326","journal-title":"Exp Lung Res"},{"issue":"5","key":"4958_CR148","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.febslet.2006.01.066","volume":"580","author":"T Mizutani","year":"2006","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2006) Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. FEBS Lett 580(5):1417\u20131424","journal-title":"FEBS Lett"},{"issue":"2","key":"4958_CR149","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virol.2004.07.005","volume":"327","author":"T Mizutani","year":"2004","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2004) Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. Virology 327(2):169\u2013174","journal-title":"Virology"},{"issue":"5624","key":"4958_CR150","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1085952","volume":"300","author":"PA Rota","year":"2003","unstructured":"Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen M-H (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300(5624):1394\u20131399","journal-title":"Science"},{"issue":"2","key":"4958_CR151","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1128\/AAC.03659-14","volume":"59","author":"J Kindrachuk","year":"2015","unstructured":"Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH (2015) Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother 59(2):1088\u20131099","journal-title":"Antimicrob Agents Chemother"},{"key":"4958_CR152","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, Kritas S (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2)"},{"issue":"3","key":"4958_CR153","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","volume":"50","author":"HT Idriss","year":"2000","unstructured":"Idriss HT, Naismith JH (2000) TNF\u03b1 and the TNF receptor superfamily: Structure-function relationship (s). Microsc Res Technol 50(3):184\u2013195","journal-title":"Microsc Res Technol"},{"key":"4958_CR154","unstructured":"Aggarwal BB, Vil\u010dek J (1992) Tumor necrosis factors: Structure, function, and mechanism of action, vol 56. Marcel Dekker Incorporated"},{"issue":"12","key":"4958_CR155","doi-asserted-by":"publisher","first-page":"7313","DOI":"10.1016\/S0021-9258(20)89445-9","volume":"266","author":"J Vilcek","year":"1991","unstructured":"Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266(12):7313\u20137316","journal-title":"J Biol Chem"},{"issue":"5","key":"4958_CR156","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1172\/JCI113482","volume":"81","author":"E Sariban","year":"1988","unstructured":"Sariban E, Imamura K, Luebbers R, Kufe D (1988) Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Investig 81(5):1506\u20131510","journal-title":"J Clin Investig"},{"issue":"1","key":"4958_CR157","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2334-8-27","volume":"8","author":"S Wang","year":"2008","unstructured":"Wang S, Wei M, Han Y, Zhang K, He L, Yang Z, Su B, Zhang Z, Hu Y, Hui W (2008) Roles of TNF-\u03b1 gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infect Dis 8(1):27","journal-title":"BMC Infect Dis"},{"key":"4958_CR158","doi-asserted-by":"crossref","unstructured":"Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19\u2014a systematic review of current evidence. Ecancermedicalscience 14","DOI":"10.3332\/ecancer.2020.1022"},{"issue":"2","key":"4958_CR159","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jmv.10475","volume":"71","author":"AE Kajon","year":"2003","unstructured":"Kajon AE, Gigliotti AP, Harrod KS (2003) Acute inflammatory response and remodeling of airway epithelium after subspecies B1 human adenovirus infection of the mouse lower respiratory tract. J Med Virol 71(2):233\u2013244","journal-title":"J Med Virol"},{"issue":"3","key":"4958_CR160","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI1355","volume":"101","author":"FG Hayden","year":"1998","unstructured":"Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Investig 101(3):643\u2013649","journal-title":"J Clin Investig"},{"issue":"5","key":"4958_CR161","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.4049\/jimmunol.175.5.3165","volume":"175","author":"A Cooper","year":"2005","unstructured":"Cooper A, Tal G, Lider O, Shaul Y (2005) Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol 175(5):3165\u20133176","journal-title":"J Immunol"},{"issue":"5","key":"4958_CR162","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","volume":"127","author":"A Dolganiuc","year":"2004","unstructured":"Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G (2004) Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127(5):1513\u20131524","journal-title":"Gastroenterology"},{"issue":"17","key":"4958_CR163","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1128\/JVI.76.17.8729-8736.2002","volume":"76","author":"K Bieback","year":"2002","unstructured":"Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, ter Meulen V, Schneider-Schaulies S (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76(17):8729\u20138736","journal-title":"J Virol"},{"issue":"5","key":"4958_CR164","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.0308057100","volume":"101","author":"EA Kurt-Jones","year":"2004","unstructured":"Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci 101(5):1315\u20131320","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"4958_CR165","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","volume":"77","author":"T Compton","year":"2003","unstructured":"Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 77(8):4588\u20134596","journal-title":"J Virol"},{"issue":"2","key":"4958_CR166","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1440-1827.1996.tb03584.x","volume":"46","author":"LH Pan","year":"1996","unstructured":"Pan LH, Ohtani H, Yamauchi K, Nagura H (1996) Co-expression of TNF\u03b1 and IL-1\u03b2 in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 46(2):91\u201399","journal-title":"Pathol Int"},{"issue":"2","key":"4958_CR167","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1164\/ajrccm.162.2.9909053","volume":"162","author":"M Whyte","year":"2000","unstructured":"Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A (2000) Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-\u03b1 gene polymorphisms. Am J Respir Crit Care Med 162(2):755\u2013758","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"4958_CR168","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMcibr070490","volume":"356","author":"S Verma","year":"2007","unstructured":"Verma S, Slutsky AS (2007) Idiopathic pulmonary fibrosis\u2014new insights. N Engl J Med 356(13):1370\u20131372","journal-title":"N Engl J Med"},{"issue":"8","key":"4958_CR169","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","volume":"72","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, Ye L, Xu S, Sun R, Wang Y (2004) Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 72(8):4410\u20134415","journal-title":"Infect Immun"},{"issue":"1","key":"4958_CR170","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12918-016-0336-6","volume":"10","author":"JE McDermott","year":"2016","unstructured":"McDermott JE, Mitchell HD, Gralinski LE, Eisfeld AJ, Josset L, Bankhead A, Neumann G, Tilton SC, Sch\u00e4fer A, Li C (2016) The effect of inhibition of PP1 and TNF\u03b1 signaling on pathogenesis of SARS coronavirus. BMC Syst Biol 10(1):93","journal-title":"BMC Syst Biol"},{"key":"4958_CR171","doi-asserted-by":"crossref","unstructured":"Hsueh P-R, Chen P-J, Hsiao C-H, Yeh S-H, Cheng W-C, Wang J-L, Chiang B-L, Chang S-C, Chang F-Y, Wong W-W (2004) Patient data, early SARS epidemic, Taiwan","DOI":"10.3201\/eid1003.030571"},{"issue":"3","key":"4958_CR172","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1378\/chest.115.3.901","volume":"115","author":"RJ Folz","year":"1999","unstructured":"Folz RJ, Elkordy MA (1999) Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer. Chest 115(3):901\u2013905","journal-title":"Chest"},{"issue":"2","key":"4958_CR173","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","volume":"324","author":"Y He","year":"2004","unstructured":"He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S (2004) Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 324(2):773\u2013781","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"4958_CR174","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","volume":"274","author":"AG Eliopoulos","year":"1999","unstructured":"Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS (1999) Activation of the p38 mitogen-activated protein kinase pathway by Epstein\u2013Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 274(23):16085\u201316096","journal-title":"J Biol Chem"},{"issue":"12","key":"4958_CR175","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.4049\/jimmunol.174.12.7977","volume":"174","author":"C-TK Tseng","year":"2005","unstructured":"Tseng C-TK, Perrone LA, Zhu H, Makino S, Peters CJ (2005) Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol 174(12):7977\u20137985","journal-title":"J Immunol"},{"issue":"22","key":"4958_CR176","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","volume":"105","author":"S Haga","year":"2008","unstructured":"Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y (2008) Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry. Proc Natl Acad Sci 105(22):7809\u20137814","journal-title":"Proc Natl Acad Sci"},{"issue":"34","key":"4958_CR177","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ (2005) Tumor necrosis factor-\u03b1 convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280(34):30113\u201330119","journal-title":"J Biol Chem"},{"key":"4958_CR178","doi-asserted-by":"crossref","unstructured":"McDonald DR, Levy O (2019) Innate immunity. In: Clinical immunology. Elsevier, pp 39\u201353 (e31)","DOI":"10.1016\/B978-0-7020-6896-6.00003-X"},{"key":"4958_CR179","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3389\/fimmu.2016.00498","volume":"7","author":"KS Schulz","year":"2016","unstructured":"Schulz KS, Mossman KL (2016) Viral evasion strategies in type I IFN signalling\u2014a summary of recent developments. Front Immunol 7:498","journal-title":"Front Immunol"},{"issue":"3","key":"4958_CR180","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.chom.2016.08.005","volume":"20","author":"M Kane","year":"2016","unstructured":"Kane M, Zang TM, Rihn SJ, Zhang F, Kueck T, Alim M, Schoggins J, Rice CM, Wilson SJ, Bieniasz PD (2016) Identification of interferon-stimulated genes with antiretroviral activity. Cell Host Microbe 20(3):392\u2013405","journal-title":"Cell Host Microbe"},{"issue":"12","key":"4958_CR181","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nri1732","volume":"5","author":"AA Dandekar","year":"2005","unstructured":"Dandekar AA, Perlman S (2005) Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 5(12):917\u2013927","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"4958_CR182","doi-asserted-by":"publisher","first-page":"e02143","DOI":"10.1128\/JVI.02143-16","volume":"91","author":"Y Hu","year":"2017","unstructured":"Hu Y, Li W, Gao T, Cui Y, Jin Y, Li P, Ma Q, Liu X, Cao C (2017) The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J Virol 91(8):e02143-e12116","journal-title":"J Virol"},{"key":"4958_CR183","doi-asserted-by":"crossref","unstructured":"Chang C-Y, Liu HM, Chang M-F, Chang SC (2020) Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling. J Virol","DOI":"10.1128\/JVI.00099-20"},{"issue":"1","key":"4958_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2016.33","volume":"5","author":"P-Y Lui","year":"2016","unstructured":"Lui P-Y, Wong L-YR, Fung C-L, Siu K-L, Yeung M-L, Yuen K-S, Chan C-P, Woo PC-Y, Yuen K-Y, Jin D-Y (2016) Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect 5(1):1\u20139","journal-title":"Emerg Microbes Infect"},{"key":"4958_CR185","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2017.12.028","volume":"515","author":"HH Wong","year":"2018","unstructured":"Wong HH, Fung TS, Fang S, Huang M, Le MT, Liu DX (2018) Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology 515:165\u2013175","journal-title":"Virology"},{"issue":"3","key":"4958_CR186","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","volume":"2","author":"AL Totura","year":"2012","unstructured":"Totura AL, Baric RS (2012) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol 2(3):264\u2013275","journal-title":"Curr Opin Virol"},{"issue":"9","key":"4958_CR187","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1128\/JVI.02406-09","volume":"84","author":"MA Clementz","year":"2010","unstructured":"Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, Ratia K, Baez-Santos YM, Wang J, Takayama J, Ghosh AK (2010) Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84(9):4619\u20134629","journal-title":"J Virol"},{"issue":"2","key":"4958_CR188","doi-asserted-by":"publisher","first-page":"e1006195","DOI":"10.1371\/journal.ppat.1006195","volume":"13","author":"E Kindler","year":"2017","unstructured":"Kindler E, Gil-Cruz C, Spanier J, Li Y, Wilhelm J, Rabouw HH, Z\u00fcst R, Hwang M (2017) V\u2019kovski P, Stalder H, Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog 13(2):e1006195","journal-title":"PLoS Pathog"},{"issue":"9","key":"4958_CR189","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s12275-019-9272-7","volume":"57","author":"JY Lee","year":"2019","unstructured":"Lee JY, Bae S, Myoung J (2019) Middle East respiratory syndrome coronavirus-encoded ORF8b strongly antagonizes IFN-\u03b2 promoter activation: its implication for vaccine design. J Microbiol 57(9):803\u2013811","journal-title":"J Microbiol"},{"issue":"5","key":"4958_CR190","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z (2014) SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein Cell 5(5):369\u2013381","journal-title":"Protein Cell"},{"key":"4958_CR191","doi-asserted-by":"publisher","first-page":"17554","DOI":"10.1038\/srep17554","volume":"5","author":"Y Yang","year":"2015","unstructured":"Yang Y, Ye F, Zhu N, Wang W, Deng Y, Zhao Z, Tan W (2015) Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets. Sci Rep 5:17554","journal-title":"Sci Rep"},{"key":"4958_CR192","doi-asserted-by":"publisher","first-page":"198074","DOI":"10.1016\/j.virusres.2020.198074","volume":"286","author":"J-Y Li","year":"2020","unstructured":"Li J-Y, Liao C-H, Wang Q, Tan Y-J, Luo R, Qiu Y, Ge X-Y (2020) The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res 286:198074","journal-title":"Virus Res"},{"issue":"1","key":"4958_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, Wang C, Wang Y, Li L, Ren L (2020) Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun 11(1):1\u201312","journal-title":"Nat Commun"},{"issue":"1","key":"4958_CR194","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY-C, Wang H, Menachery VD, Rajsbaum R, Shi P-Y (2020) Evasion of type I Interferon by SARS-CoV-2. Cell Rep 33(1):108234","journal-title":"Cell Rep"},{"key":"4958_CR195","doi-asserted-by":"publisher","first-page":"104811","DOI":"10.1016\/j.antiviral.2020.104811","volume":"179","author":"E Mantlo","year":"2020","unstructured":"Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C (2020) Antiviral activities of type I interferons to SARS-CoV-2 infection. Antivir Res 179:104811","journal-title":"Antivir Res"},{"key":"4958_CR196","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cid\/ciaa453","volume":"71","author":"TR O\u2019Brien","year":"2020","unstructured":"O\u2019Brien TR, Thomas DL, Jackson SS, Prokunina-Olsson L, Donnelly RP, Hartmann R (2020) Weak induction of interferon expression by SARS-CoV-2 supports clinical trials of interferon lambda to treat early COVID-19. Clin Infect Dis 71:1410\u20131412","journal-title":"Clin Infect Dis"},{"key":"4958_CR197","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu W-C, Uhl S, Hoagland D, M\u00f8ller R, Jordan TX, Oishi K, Panis M, Sachs D (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181:1036\u20131045","journal-title":"Cell"},{"key":"4958_CR198","unstructured":"Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD (2020) SARS-CoV-2 sensitive to type I interferon pretreatment. BioRxiv"},{"key":"4958_CR199","first-page":"1","volume":"199","author":"C-K Yuen","year":"2020","unstructured":"Yuen C-K, Lam J-Y, Wong W-M, Mak L-F, Wang X, Chu H, Cai J-P, Jin D-Y, To KK-W, Chan JF-W (2020) SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect 199:1\u201329","journal-title":"Emerg Microbes Infect"},{"key":"4958_CR200","unstructured":"Lokugamage KG, Hage A, Schindewolf C, Rajsbaum R, Menachery VD (2020) SARS-CoV-2 is sensitive to type I interferon pretreatment. BioRxiv"},{"issue":"41","key":"4958_CR201","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer U, Schoen A, Gad HH, Hartmann R, Schaubmar AR, Failing K, Drosten C, Weber F (2020) Inhibition of SARS\u2013CoV-2 by type I and type III interferons. J Biol Chem 295(41):13958\u201313964","journal-title":"J Biol Chem"},{"key":"4958_CR202","doi-asserted-by":"crossref","unstructured":"Dunn EF, Connor JH (2012) HijAkt: the PI3K\/Akt pathway in virus replication and pathogenesis. In: Progress in molecular biology and translational science, vol 106. Elsevier, pp 223\u2013250","DOI":"10.1016\/B978-0-12-396456-4.00002-X"},{"issue":"1","key":"4958_CR203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Yang L, Fikrig E, Wang P (2017) An essential role of PI3K in the control of West Nile virus infection. Sci Rep 7(1):1\u20139","journal-title":"Sci Rep"},{"issue":"12","key":"4958_CR204","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.3390\/v5123192","volume":"5","author":"N Diehl","year":"2013","unstructured":"Diehl N, Schaal H (2013) Make yourself at home: viral hijacking of the PI3K\/Akt signaling pathway. Viruses 5(12):3192\u20133212","journal-title":"Viruses"},{"issue":"3","key":"4958_CR205","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/187220808786241042","volume":"2","author":"W-T Ji","year":"2008","unstructured":"Ji W-T, Liu HJ (2008) PI3K-Akt signaling and viral infection. Recent Pat Biotechnol 2(3):218\u2013226","journal-title":"Recent Pat Biotechnol"},{"issue":"8","key":"4958_CR206","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1462-5822.2006.00713.x","volume":"8","author":"C Ehrhardt","year":"2006","unstructured":"Ehrhardt C, Marjuki H, Wolff T, N\u00fcrnberg B, Planz O, Pleschka S, Ludwig S (2006) Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 8(8):1336\u20131348","journal-title":"Cell Microbiol"},{"key":"4958_CR207","doi-asserted-by":"crossref","unstructured":"Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S (2006) Characterization of persistent SARS-CoV. Nidoviruses 324, vol. 581","DOI":"10.1007\/978-0-387-33012-9_57"},{"issue":"2","key":"4958_CR208","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.abb.2007.01.012","volume":"459","author":"C-M Chan","year":"2007","unstructured":"Chan C-M, Ma C-W, Chan W-Y, Chan HYE (2007) The SARS-Coronavirus Membrane protein induces apoptosis through modulating the Akt survival pathway. Arch Biochem Biophys 459(2):197\u2013207","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"4958_CR209","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4269\/ajtmh.20-0986","volume":"103","author":"A Sarkesh","year":"2020","unstructured":"Sarkesh A, Sorkhabi AD, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Baghi HB (2020) Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg 103(5):1783\u20131796","journal-title":"Am J Trop Med Hyg"},{"key":"4958_CR210","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fgene.2020.00641","volume":"11","author":"N Hemmat","year":"2020","unstructured":"Hemmat N, Derakhshani A, Bannazadeh Baghi H, Silvestris N, Baradaran B, De Summa S (2020) Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: a bioinformatics study. Front Genet 11:641","journal-title":"Front Genet"},{"key":"4958_CR211","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2394-5079.158391","volume":"1","author":"HK Cho","year":"2015","unstructured":"Cho HK, Kim JR, Kim SY, Kyaw YY, Win AA, Cheong JH (2015) Sorafenib suppresses hepatitis B virus gene expression via inhibiting JNK pathway. Hepatoma Res 1:97\u2013103","journal-title":"Hepatoma Res"},{"issue":"18","key":"4958_CR212","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","volume":"77","author":"J Dyall","year":"2017","unstructured":"Dyall J, Gross R, Kindrachuk J, Johnson RF, Olinger GG, Hensley LE, Frieman MB, Jahrling PB (2017) Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs 77(18):1935\u20131966","journal-title":"Drugs"},{"key":"4958_CR213","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.12659\/MSM.899804","volume":"23","author":"Q Dai","year":"2017","unstructured":"Dai Q, Di Zhang HY, Xie W, Xin R, Wang L, Xu X, He X, Xiong J, Sheng H, Le Zhang KZ (2017) Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK activation in vitro. Med Sci Monit 23:1448","journal-title":"Med Sci Monit"},{"issue":"9","key":"4958_CR214","first-page":"1935","volume":"165","author":"A Warowicka","year":"2020","unstructured":"Warowicka A, Nawrot R, Go\u017adzicka-J\u00f3zefiak A (2020) Antiviral activity of berberine. Adv Virol 165(9):1935\u20131945","journal-title":"Adv Virol"},{"key":"4958_CR215","doi-asserted-by":"publisher","first-page":"104878","DOI":"10.1016\/j.antiviral.2020.104878","volume":"181","author":"A Pizzorno","year":"2020","unstructured":"Pizzorno A, Padey B, Dubois J, Julien T, Traversier A, Duli\u00e8re V, Brun P, Lina B, Rosa-Calatrava M, Terrier O (2020) In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antivir Res 181:104878","journal-title":"Antivir Res"},{"issue":"12","key":"4958_CR216","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jmv.24286","volume":"87","author":"H Zhang","year":"2015","unstructured":"Zhang H, Niu X, Qian Z, Qian J, Xuan B (2015) The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication. J Med Virol 87(12):2135\u20132144","journal-title":"J Med Virol"},{"key":"4958_CR217","doi-asserted-by":"crossref","unstructured":"Cicenas J, Zalyte E, Rimkus A, Dapkus D, Noreika R, Urbonavicius S (2018) JNK, p38, ERK, and SGK1 inhibitors in cancer. Multidisciplinary Digital Publishing Institute","DOI":"10.3390\/cancers10010001"},{"key":"4958_CR218","doi-asserted-by":"crossref","unstructured":"Cerbone A, Toaldo C, Pizzimenti S, Pettazzoni P, Dianzani C, Minelli R, Ciamporcero E, Roma G, Dianzani MU, Canaparo R (2012) AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells. PPAR Res 2012","DOI":"10.1155\/2012\/269751"},{"issue":"1\u20132","key":"4958_CR219","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000431100","volume":"96","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wang Z, Jiang Y, Lu M, Li X (2015) Ginsenoside Rg1 ameliorates motor function in an animal model of Parkinson\u2019s disease. Pharmacology 96(1\u20132):25\u201331","journal-title":"Pharmacology"},{"issue":"10","key":"4958_CR220","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.18632\/oncotarget.600","volume":"3","author":"JP De Boer","year":"2012","unstructured":"De Boer JP, van Egmond PW, Helder MN, de Menezes RX, Cleton-Jansen A-M, Beli\u00ebn JA, Verheul HM, van Royen BJ (2012) Kaspers G-JJ, van Beusechem VW, Targeting JNK-interacting protein 1 (JIP1) sensitises osteosarcoma to doxorubicin. Oncotarget 3(10):1169","journal-title":"Oncotarget"},{"issue":"3","key":"4958_CR221","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/aps.2016.160","volume":"38","author":"A-r Su","year":"2017","unstructured":"Su A-r (2017) Qiu M, Li Y-l, Xu W-t, Song S-w, Wang X-h, Song H-y, Zheng N, Wu Z-w, BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK\/p38 pathways without interfering with PDK1 activity in host cells. Acta Pharmacol Sin 38(3):402\u2013414","journal-title":"Acta Pharmacol Sin"},{"key":"4958_CR222","doi-asserted-by":"crossref","unstructured":"Koff J, Min-Oo G, Ballon-Landa E, Kalinowski A, Ueki I, Lanier L, Nadel JA (2012) EGFR inhibition suppresses respiratory viral infection in vitro and in vivo. In: D73. receptor input of airway networking. American Thoracic Society, p A6274","DOI":"10.1164\/ajrccm-conference.2012.185.1_MeetingAbstracts.A6274"},{"issue":"1","key":"4958_CR223","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0304-3835(01)00547-X","volume":"169","author":"X-F Zhu","year":"2001","unstructured":"Zhu X-F, Liu Z-C, Xie B-F, Li Z-M, Feng G-K, Yang D, Zeng Y-X (2001) EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells. Cancer Lett 169(1):27\u201332","journal-title":"Cancer Lett"},{"key":"4958_CR224","first-page":"100763","volume":"22","author":"CJ Gan","year":"2020","unstructured":"Gan CJ, Li WF, Li CN, Li LL, Zhou WY, Peng XM (2020) EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation. Biochem Biophys Rep 22:100763","journal-title":"Biochem Biophys Rep"},{"key":"4958_CR225","doi-asserted-by":"crossref","unstructured":"Metro G, Finocchiaro G, Cappuzzo F (2006) Anti-cancer therapy with EGFR inhibitors: factors of prognostic and predictive significance. Ann Oncol 17:ii42\u2013ii45","DOI":"10.1093\/annonc\/mdj920"},{"issue":"18","key":"4958_CR226","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1158\/0008-5472.CAN-04-1168","volume":"64","author":"ER Wood","year":"2004","unstructured":"Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A, Dickerson SH, Ellis B, Pennisi C, Horne E, Lackey K (2004) A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Can Res 64(18):6652\u20136659","journal-title":"Can Res"},{"issue":"9","key":"4958_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-020-02851-7","volume":"37","author":"E Weisberg","year":"2020","unstructured":"Weisberg E, Parent A, Yang PL, Sattler M, Liu Q, Liu Q, Wang J, Meng C, Buhrlage SJ, Gray N (2020) Repurposing of kinase inhibitors for treatment of COVID-19. Pharm Res 37(9):1\u201329","journal-title":"Pharm Res"},{"key":"4958_CR228","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lungcan.2016.01.003","volume":"93","author":"C-S Tan","year":"2016","unstructured":"Tan C-S, Cho B-C, Soo RA (2016) Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor-mutant non-small cell lung cancer. Lung cancer 93:59\u201368","journal-title":"Lung cancer"},{"issue":"5434","key":"4958_CR229","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","volume":"285","author":"PG Komarov","year":"1999","unstructured":"Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285(5434):1733\u20131737","journal-title":"Science"},{"key":"4958_CR230","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2017.09.053","volume":"414","author":"NC Synnott","year":"2018","unstructured":"Synnott NC, Bauer MR, Madden S, Murray A, Klinger R, O\u2019Donovan N, O\u2019Connor D, Gallagher WM, Crown J, Fersht AR (2018) Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigation with the anti-p53 drug, PK11007. Cancer Lett 414:99\u2013106","journal-title":"Cancer Lett"},{"key":"4958_CR231","first-page":"1","volume":"23","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu L, Chang Y, Li Y, Butler W, Jin E, Wang A, Tao Y, Chen X, Liang C (2019) Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC. Prostate Cancer Prostat Dis 23:1\u201312","journal-title":"Prostate Cancer Prostat Dis"},{"issue":"5","key":"4958_CR232","doi-asserted-by":"publisher","first-page":"L895","DOI":"10.1152\/ajplung.2000.279.5.L895","volume":"279","author":"DC Underwood","year":"2000","unstructured":"Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE (2000) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 279(5):L895\u2013L902","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"4958_CR233","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1124\/jpet.106.106054","volume":"319","author":"J Prakash","year":"2006","unstructured":"Prakash J, Sandovici M, Saluja V, Lacombe M, Schaapveld RQ, De Borst MH, Van Goor H, Henning RH, Proost JH, Moolenaar F (2006) Intracellular delivery of the p38 mitogen-activated protein kinase inhibitor SB202190 [4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl) 1H-imidazole] in renal tubular cells: a novel strategy to treat renal fibrosis. J Pharmacol Exp Ther 319(1):8\u201319","journal-title":"J Pharmacol Exp Ther"},{"key":"4958_CR234","doi-asserted-by":"crossref","unstructured":"Herman AP, Krawczy\u0144ska A, Bochenek J, Antushevich H, Herman A, Tomaszewska-Zaremba D (2014) Peripheral injection of SB203580 inhibits the inflammatory-dependent synthesis of proinflammatory cytokines in the hypothalamus. BioMed Res Int 2014","DOI":"10.1155\/2014\/475152"},{"issue":"5","key":"4958_CR235","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1080\/15384047.2016.1177676","volume":"17","author":"X Jin","year":"2016","unstructured":"Jin X, Mo Q, Zhang Y, Gao Y, Wu Y, Li J, Hao X, Ma D, Gao Q, Chen P (2016) The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer. Cancer Biol Ther 17(5):566\u2013576","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"4958_CR236","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/01.CCM.0B013E31816204FA","volume":"36","author":"M Asaduzzaman","year":"2008","unstructured":"Asaduzzaman M, Wang Y, Thorlacius H (2008) Critical role of p38 mitogen-activated protein kinase signaling in septic lung injury. Crit Care Med 36(2):482\u2013488","journal-title":"Crit Care Med"},{"issue":"1","key":"4958_CR237","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbrc.2005.08.082","volume":"336","author":"M Ohori","year":"2005","unstructured":"Ohori M, Kinoshita T, Okubo M, Sato K, Yamazaki A, Arakawa H, Nishimura S, Inamura N, Nakajima H, Neya M (2005) Identification of a selective ERK inhibitor and structural determination of the inhibitor\u2013ERK2 complex. Biochem Biophys Res Commun 336(1):357\u2013363","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4958_CR238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-1537-9","volume":"39","author":"F Wang","year":"2020","unstructured":"Wang F, Li D, Zheng Z, To KKW, Chen Z, Zhong M, Su X, Chen L, Fu L (2020) Reversal of ABCB1-related multidrug resistance by ERK5-IN-1. J Exp Clin Cancer Res 39(1):1\u201313","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"4958_CR239","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","volume":"10","author":"K Lis","year":"2014","unstructured":"Lis K, Kuzawi\u0144ska O, Ba\u0142kowiec-Iskra E (2014) Tumor necrosis factor inhibitors\u2013state of knowledge. Arch Med Sci 10(6):1175","journal-title":"Arch Med Sci"},{"issue":"1","key":"4958_CR240","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1185\/030079903125002757","volume":"20","author":"E Tobinick","year":"2004","unstructured":"Tobinick E (2004) TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection. Curr Med Res Opin 20(1):39\u201340","journal-title":"Curr Med Res Opin"},{"key":"4958_CR241","unstructured":"Chen G, Guo Y, Yutian W (2016) Celastrol inhibits tumor necrosis factor-alpha induced proliferation and inflammatory responses in RAW264. 7 cells. Chin J Tissue Eng Res 20(37):5552\u20135559"},{"issue":"8","key":"4958_CR242","first-page":"1205","volume":"11","author":"S Law","year":"2020","unstructured":"Law S, Leung AW, Xu C (2020) Is the traditional Chinese herb, \"Celastrol\" effective to combat COVID-19? J Mater Environ Sci 11(8):1205\u20131208","journal-title":"J Mater Environ Sci"},{"key":"4958_CR243","doi-asserted-by":"crossref","unstructured":"Habtemariam S, Nabavi SF, Berindan\u2010Neagoe I, Cismaru CA, Izadi M, Sureda A, Nabavi SM (2020) Should we try the antiinflammatory natural product, celastrol, for COVID\u201019? Phytother Res","DOI":"10.1002\/ptr.6711"},{"issue":"3","key":"4958_CR244","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3892\/etm.2017.4749","volume":"14","author":"SP Liu","year":"2017","unstructured":"Liu SP, Wang GD, Du XJ, Wan G, Wu JT, Miao LB, Liang QD (2017) Triptolide inhibits the function of TNF-\u03b1 in osteoblast differentiation by inhibiting the NF-\u03baB signaling pathway. Exp Ther Med 14(3):2235\u20132240","journal-title":"Exp Ther Med"},{"key":"4958_CR245","doi-asserted-by":"crossref","unstructured":"Chaparala S, Iwema CL, Chattopadhyay A (2020) SARS-CoV-2 infections-gene expression omnibus (GEO) data mining, pathway enrichment analysis, and prediction of repurposable drugs\/compounds","DOI":"10.20944\/preprints202009.0459.v1"},{"issue":"9","key":"4958_CR246","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bcp.2009.12.021","volume":"79","author":"SC Miller","year":"2010","unstructured":"Miller SC, Huang R, Sakamuru S, Shukla SJ, Attene-Ramos MS, Shinn P, Van Leer D, Leister W, Austin CP, Xia M (2010) Identification of known drugs that act as inhibitors of NF-\u03baB signaling and their mechanism of action. Biochem Pharmacol 79(9):1272\u20131280","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"4958_CR247","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1128\/JVI.00485-10","volume":"84","author":"M Raaben","year":"2010","unstructured":"Raaben M, Posthuma CC, Verheije MH, Te Lintelo EG, Kikkert M, Drijfhout JW, Snijder EJ, Rottier PJ, De Haan CA (2010) The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol 84(15):7869\u20137879","journal-title":"J Virol"},{"key":"4958_CR248","doi-asserted-by":"publisher","first-page":"107325","DOI":"10.1016\/j.compbiolchem.2020.107325","volume":"88","author":"A Jim\u00e9nez-Alberto","year":"2020","unstructured":"Jim\u00e9nez-Alberto A, Ribas-Aparicio RM, Aparicio-Ozores G, Castel\u00e1n-Vega JA (2020) Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors. Comput Biol Chem 88:107325","journal-title":"Comput Biol Chem"},{"key":"4958_CR249","doi-asserted-by":"crossref","unstructured":"Cho J, Lee YJ, Kim JH, Il Kim S, Kim SS, Choi B-S, Choi J-H (2020) Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep 10(1):1\u20138","DOI":"10.1038\/s41598-020-72879-7"},{"issue":"8","key":"4958_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-02842-x","volume":"11","author":"A Sauvat","year":"2020","unstructured":"Sauvat A, Ciccosanti F, Colavita F, Di Rienzo M, Castilletti C, Capobianchi MR, Kepp O, Zitvogel L, Fimia GM, Piacentini M (2020) On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death Dis 11(8):1\u201311","journal-title":"Cell Death Dis"},{"key":"4958_CR251","doi-asserted-by":"crossref","unstructured":"Ghahremanpour MM, Tirado-Rives J, Deshmukh M, Ippolito JA, Zhang C-H, de Vaca IC, Liosi M-E, Anderson KS, Jorgensen WL (2020) Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. bioRxiv","DOI":"10.1101\/2020.08.28.271957"},{"key":"4958_CR252","unstructured":"Guo K, Wang Z, Gao P, Pu Q, Wu M, Huang C, Hur J (2020) Identification of repurposal drugs and adverse drug reactions for various courses of coronavirus disease 2019 (COVID-19) based on single-cell RNA sequencing data. arXiv:200507856"},{"key":"4958_CR253","doi-asserted-by":"crossref","unstructured":"Klann K, Bojkova D, Tascher G, Ciesek S, M\u00fcnch C, Cinatl J (2020) Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication. bioRxiv","DOI":"10.1101\/2020.05.14.095661"},{"key":"4958_CR254","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1038\/srep28597","volume":"6","author":"H Xiao","year":"2016","unstructured":"Xiao H, Zhang J, Xu Z, Feng Y, Zhang M, Liu J, Chen R, Shen J, Wu J, Lu Z (2016) Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21. Sci Rep 6:28597","journal-title":"Sci Rep"},{"key":"4958_CR255","doi-asserted-by":"crossref","unstructured":"Sharma S, Ray A, Sadasivam B (2020) Metformin in COVID-19: a possible role beyond diabetes. Diabetes Res Clin Pract 164:108\u2013183","DOI":"10.1016\/j.diabres.2020.108183"},{"issue":"1","key":"4958_CR256","doi-asserted-by":"publisher","first-page":"e1257453","DOI":"10.1080\/2162402X.2016.1257453","volume":"6","author":"A de Gramont","year":"2016","unstructured":"de Gramont A, Faivre S, Raymond E (2016) Novel TGF-\u03b2 inhibitors ready for prime time in onco-immunology. Oncoimmunology 6(1):e1257453\u2013e1257453","journal-title":"Oncoimmunology"},{"issue":"11","key":"4958_CR257","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/biom9110743","volume":"9","author":"LK Huynh","year":"2019","unstructured":"Huynh LK, Hipolito CJ, Ten Dijke P (2019) A perspective on the development of tgf-\u03b2 inhibitors for cancer treatment. Biomolecules 9(11):743","journal-title":"Biomolecules"},{"issue":"42","key":"4958_CR258","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1038\/sj.onc.1210448","volume":"26","author":"E Suzuki","year":"2007","unstructured":"Suzuki E, Umezawa K, Bonavida B (2007) Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis. Oncogene 26(42):6184\u20136193","journal-title":"Oncogene"},{"key":"4958_CR259","doi-asserted-by":"publisher","first-page":"175346662091515","DOI":"10.1177\/1753466620915156","volume":"14","author":"F Wang","year":"2020","unstructured":"Wang F, Meng F, Wong SCC, Cho WC, Yang S, Chan LW (2020) Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K\/AKT pathway in non-small cell lung cancer. Ther Adv Respir Dis 14:1753466620915156","journal-title":"Ther Adv Respir Dis"},{"key":"4958_CR260","doi-asserted-by":"crossref","unstructured":"Lan W, Zhao J, Shang H, Peng J, Chen W, Lin J (2019) Anlotinib overcomes multiple drug resistant of the colorectal cancer cells via inactivating PI3K\/AKT pathway. bioRxiv 821801","DOI":"10.1101\/821801"},{"key":"4958_CR261","first-page":"1128","volume":"68","author":"R Bhatt","year":"2008","unstructured":"Bhatt R, Zhang L, Schor-Bardach R, Libermann T, Atkins M, Goldberg N, Kumar M, Mier J (2008) Effects of sorafenib administration on the IFN signaling pathway and on the expression of IFN-inducible genes in RCC tumor cells. AACR 68:1128","journal-title":"AACR"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-021-04958-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T15:25:19Z","timestamp":1674919519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-021-04958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":261,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4958"],"URL":"https:\/\/doi.org\/10.1007\/s00705-021-04958-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"5 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}